Fortress Biotech, Inc. (FBIO) Stock Price

FBIOStock
$2.83+29.07%52W
Market Cap$94.38M
P/E14.09x
PEG Ratio
Div yield
Beta1.22

FBIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-26.32%
Price vs S&P 500 (4W)-16.62%
VGM Score64.45
P/E Ratio (Annual)14.09x

FBIO Earnings Surprise History

Q2 25-0.51est. -0.31
Q3 250.11est. -0.63
Q4 25-0.21est. 0.11
Q1 262.82est. -0.22
Q2 26-0.08est. -0.20

FBIO Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.13
4.13
4.13
4.13

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
FBIOFortress Biotech, Inc.
BBC$2.83
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Fortress Biotech, Inc.

Fortress Biotech is a biopharmaceutical company focused on acquiring, developing, and commercializing dermatology and therapeutic products. Its portfolio includes key dermatology brands—Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm—which represent the majority of revenues. The company also operates in oncology and other therapeutic sectors through its subsidiaries.